Publicacións nas que colabora con María José Bermudez (12)

2022

  1. Conditioned Medium from Human Uterine Cervical Stem Cells Regulates Oxidative Stress and Angiogenesis of Retinal Pigment Epithelial Cells

    Ophthalmic research, Vol. 65, Núm. 5, pp. 556-565

2021

  1. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  2. LIPG endothelial lipase and breast cancer risk by subtypes

    Scientific Reports, Vol. 11, Núm. 1

2019

  1. Corneal regeneration by conditioned medium of human uterine cervical stem cells is mediated by TIMP-1 and TIMP-2

    Experimental Eye Research, Vol. 180, pp. 110-121

2017

  1. Erratum to: Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13

    Breast cancer research : BCR

  2. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis

    Experimental Eye Research, Vol. 149, pp. 84-92

  2. Biological evaluation of new vitamin D2 analogues

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 164, pp. 66-71

2015

  1. Corneal epithelial wound healing and bactericidal effect of conditioned medium from human uterine cervical stem cells

    Investigative Ophthalmology and Visual Science, Vol. 56, Núm. 2, pp. 983-992

2014

  1. 26,26,26,27,27,27-hexadeuterated-1,25-dihydroxyvitamin D3 (1,25D-d6) as adjuvant of chemotherapy in breast cancer cell lines

    Cancers, Vol. 6, Núm. 1, pp. 67-78

  2. Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13

    Breast Cancer Research, Vol. 16, Núm. 1

  3. Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells

    Oncotarget, Vol. 5, Núm. 21, pp. 10692-10708